Becton Dickinson
American multinational medical technology company
BDX NYSE
ISIN US0758871091 SEC CIK 10795 LEI ICE2EP6D98PQUILVRZ91
Follow Becton Dickinson
Weekly email: filings, results
Revenue, last quarter
$5B
+5.4% vs same quarter last year
Net income
$377M
−34.3% vs same quarter last year
EPS, diluted
$1.37
−31.5% vs same quarter last year
Operating cash flow
$776M
−28.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $21.8B | $1.7B |
| FY24 | $20.2B | $1.7B |
| FY23 | $19.4B | $1.5B |
| FY22 | $18.9B | $1.8B |
| FY21 | $19.1B | $2.1B |
| FY20 | $16.1B | $874M |
| FY19 | $17.3B | $1.2B |
| FY18 | $16B | $311M |
| FY17 | $12.1B | $1.1B |
| FY16 | $12.5B | $976M |
| FY15 | $10.3B | $695M |
| FY14 | $8.4B | $1.2B |
| FY13 | $8.1B | $1.3B |
| FY12 | $7.7B | $1.2B |
| FY11 | $7.6B | $1.3B |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 45.4% | 11.8% | 7.7% |
| FY24 | 45.2% | 11.9% | 8.4% |
| FY23 | 42.2% | 10.9% | 7.7% |
| FY22 | 44.9% | 12.1% | 9.4% |
| FY21 | 45.1% | 11.8% | 10.9% |
| FY20 | 47.1% | 5.7% | 5.4% |
| FY19 | 47.9% | 10.2% | 7.1% |
| FY18 | 45.5% | 9.4% | 1.9% |
| FY17 | 49.1% | 12.6% | 9.1% |
| FY16 | 48% | 11.5% | 7.8% |
| FY15 | 45.7% | 10.4% | 6.8% |
| FY14 | 50.9% | 19% | 14% |
| FY13 | 51.8% | 15.6% | 16.1% |
| FY12 | 51.3% | 20.2% | 15.2% |
| FY11 | 52.2% | 22% | 16.8% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $2.7B |
| FY24 | $3.1B |
| FY23 | $2.1B |
| FY22 | $1.5B |
| FY21 | $3.5B |
| FY20 | $2.8B |
| FY19 | $2.4B |
| FY18 | $2B |
| FY17 | $1.8B |
| FY16 | $1.9B |
| FY15 | $1.1B |
| FY14 | $1.2B |
| FY13 | $1.2B |
| FY12 | $1.2B |
| FY11 | $1.1B |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $1.2B | $1B |
| FY24 | $1.1B | $500M |
| FY23 | $1.1B | $0 |
| FY22 | $1.1B | $500M |
| FY21 | $1B | $1.8B |
| FY20 | $1B | $0 |
| FY19 | $984M | $0 |
| FY18 | $927M | $0 |
| FY17 | $677M | $220M |
| FY16 | $562M | $0 |
| FY15 | $485M | $0 |
| FY14 | $421M | $400M |
| FY13 | $386M | $450M |
| FY12 | $368M | $1.5B |
| FY11 | $361M | $1.5B |
- Becton Dickinson
- Healthcare median
Show the numbers
| Year | Becton Dickinson | Healthcare median |
|---|---|---|
| FY25 | 7.7% | −30.6% |
| FY24 | 8.4% | −47% |
| FY23 | 7.7% | −58% |
| FY22 | 9.4% | −80.4% |
| FY21 | 10.9% | −71.9% |
| FY20 | 5.4% | −62.2% |
| FY19 | 7.1% | −46.3% |
| FY18 | 1.9% | −49.6% |
| FY17 | 9.1% | −45.9% |
| FY16 | 7.8% | −36% |
| FY15 | 6.8% | −38.4% |
| FY14 | 14% | −35.5% |
| FY13 | 16.1% | −37.1% |
| FY12 | 15.2% | −29.1% |
| FY11 | 16.8% | −27.9% |